SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is gaining significant attention as investors speculate on its position as a digital asset infrastructure play, with the community actively tracking its correlation to the HYPE token and the broader rise in perpetual futures trading. Discussions are dominated by potential institutional interest and the stock's role as a crypto-equity hybrid, despite ongoing debates regarding dilution and its historical performance.

Zoracles

Zoracles is drawing significant attention as investors speculate on potential price rebounds, with many viewing current pullbacks as strategic accumulation opportunities. The community remains focused on the token's integration with the Base ecosystem and its potential utility as a creator-focused asset, despite broader market volatility and mixed sentiment regarding its short-term price action.

TKO Group Holdings, Inc. engages in the provision of sports and entertainment. It operates through the following segments: Ultimate Fighting Championship (UFC), World Wrestling Entertainment (WWE), and IMG. The UFC segment refers to a global sports brand and media content company. The WWE segment is involved in media organizations and global leaders in sports entertainment. The IMG segment manages the operations of the IMG business and on location. The company was founded on March 29, 2023 and is headquartered in New York, NY.

TKO Group Holdings Inc - Ordinary Shares - Class A

TKO GROUP HLDGS INC

TKO is currently a major point of discussion due to the historic scheduling of a high-profile UFC event at the White House, fueling debate among investors about the event's commercial viability and potential financial impact. Simultaneously, the community is actively debating the stock's long-term valuation and structural health, with some market participants highlighting institutional accumulation and S&P 500 inclusion, while others express concerns over content strategy and accounting practices.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors focus on the company's oncology pipeline following major data updates from the HARMONi-6 trial and its upcoming PDUFA date. The community is actively debating the potential for ivonescimab to challenge existing standards of care, with sentiment split between bullish enthusiasm over clinical results and concerns regarding trial design and regulatory pathways.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors highlight its vision as a decentralized, AI-native alternative to GitHub, specifically designed for autonomous agents to manage repositories and coordinate tasks on-chain. The community is actively discussing the project's aggressive supply reduction plans, potential exchange listings, and strategic partnerships, with many focusing on its long-term utility in the evolving AI infrastructure stack.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending due to the company's recent strategic pivot away from COVID-19 revenue toward a diversified oncology pipeline, which includes multiple late-stage clinical trials. Community sentiment is mixed, with some investors optimistic about the potential of their bispecific antibody and ADC programs to disrupt the standard of care, while others remain skeptical about the leadership transition and the long-term viability of mRNA technology.

Chronobank

Chronobank is currently generating significant community buzz due to a recent security incident involving the unauthorized minting of tokens, prompting the company to initiate buybacks and burns to stabilize supply. Investors are closely monitoring the asset's low circulating supply and potential for volatility, with many debating whether it functions as a long-term utility play or a speculative pump-and-dump opportunity.

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Arvinas Inc

Arvinas is currently in the spotlight following the FDA's early approval of VEPPANU for advanced breast cancer, marking the first-ever authorization of a PROTAC therapy and validating the company's protein degradation platform. While some investors remain cautious about the company's cash burn and commercialization strategy, community discussion is heavily focused on the stock's significant upside potential, strong institutional interest, and anticipation for future pipeline catalysts.

Quanta Services, Inc. engages in the provision of comprehensive infrastructure solutions to the electric power, oil and gas, communication, pipeline, and energy industries. It operates through the following segments: Electric Power, Renewable Energy, and Underground and Infrastructure. The Electric Power segment provides services for the electric power and communications markets. The Renewable Energy segment is involved in providing infrastructure solutions to customers involved in the renewable energy industry. The Underground and Infrastructure segment offers infrastructure solutions to customers involved in the transportation, distribution, storage, development, and processing of natural gas, oil, and other products. The company was founded by Kevin D. Miller, Steven P. Colmar, William G. Parkhouse, and John R. Colson on August 19, 1997 and is headquartered in Houston, TX.

Quanta Services, Inc.

Quanta Services is trending as investors capitalize on the company's vital role in the massive U.S. power grid modernization and AI-driven data center build-out. The community is focused on Quanta's record backlog and its position as a primary infrastructure provider for the energy transition, often highlighting it alongside other key grid-related stocks in the infrastructure sector.

Eaton Corp. Plc is a power management company, which provides energy-efficient solutions for electrical, hydraulic, and mechanical power. It operates through the following segments: Electrical Americas and Electrical Global; Aerospace, Vehicle, and eMobility. The Electrical Americas and Electrical Global segments engage in sales contracts for electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality, wiring devices, circuit protection, utility power distribution, power reliability equipment, and service. The Aerospace segment supplies aerospace fuel, hydraulics, and pneumatic systems for commercial and military use. The Vehicle segment deals with the design, manufacture, marketing, and supply of drivetrain and powertrain systems and critical components that reduce emissions and improve fuel economy, stability, performance and safety of cars, light trucks and commercial vehicles. The eMobility segment designs, manufactures, markets, and supplies electrical and electronic components and systems that improve the power management and performance of both on-road and off-road vehicles. The company was founded in 1911 and is headquartered in Dublin, Ireland.

Eaton Corporation plc

Eaton is gaining significant community attention as a critical backbone for AI data center infrastructure, with investors closely watching its power management solutions amid the massive electrical grid buildout. The company is actively collaborating with industry leaders to support high-density GPU deployments, fueling long-term bullish sentiment despite recent short-term price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bitcoin ETFs Just Had The Worst Month Of The Year: Are Investors Rotating to Stocks?

American investors are dumping their Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) as the coin continues to underperform the stock market amid the artificial interead more...

Trump's American Bitcoin Is Following MicroStrategy, But Shareholders Feel the Pain

Trump's American Bitcoin Is Following MicroStrategy, But Shareholders Feel the Pain...

Eric Trump Spotlights JPMorgan's Bitcoin Turnaround, While His American Bitcoin Eyes Hoarding 'Cheapest' BTC Possible

American Bitcoin (NASDAQ:ABTC) Posts Earnings Results, Misses Estimates By $0.09 EPS

American Bitcoin (NASDAQ:ABTC - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.09). American Bitcoin had a negative net margin of 46.41% and a negative return on equity of...

American Bitcoin Q1 Earnings Call Highlights

American Bitcoin (NASDAQ:ABTC) reported first-quarter fiscal 2026 results highlighting higher Bitcoin production, lower unit mining costs, and continued growth in its Bitcoin reserve, even as Bitcoin prices declined during the quarter and created significant non-cash accounting losses under fair val...

American Bitcoin Corp. (ABTC) Reports Q1 Loss, Misses Revenue Estimates

American Bitcoin Corp. (ABTC) delivered earnings and revenue surprises of -1,700.00% and -17.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

American Bitcoin Reports First Quarter 2026 Results

American Bitcoin Reports First Quarter 2026 Results American Bitcoin Reports First Quarter 2026 Results PR Newswire MIAMI, May 6, 2026 Grew Strategic Reserve to Over 7,000 Bitcoin, a ~30% Increase in...

HUT 8’s AI Pivot Is Paying Off Faster Than Expected – HUT Stock Nears $100

Cryptocurrency

HUT stock’s rally followed the announcement of a 15-year, $9.8 billion data center lease in Texas tied to AI infrastructure.

CRCL, COIN, MSTR Stocks Gain With Bitcoin Above $81,000 For The First Time Since January

Shares of Circle Internet Group led large-cap gains, while retail sentiment on Stocktwits around the company flipped to ‘extremely bullish’ from ‘bearish’ over the past day.


Hut 8 Swaps Costly Coinbase Debt For FalconX Credit — And Unlocks 3,300 Bitcoin Ahead Of Earnings

Hut 8 replaced its Bitcoin-backed loan from Coinbase with a $200 million credit facility from FalconX.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

ABTC
American Bitcoin Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest ABTC News

ABTCAmerican Bitcoin Corp.